Senshu Ikeda and Shiga Bank Discuss Kansai Merger
The Japanese lenders confirmed merger talks, but said no decision has been made; a combined group would hold ¥14.6 trillion in assets.
Stocks
Markets, companies and the economy, from New York and Frankfurt to Istanbul and Tokyo.
Page 20 of 89
The Japanese lenders confirmed merger talks, but said no decision has been made; a combined group would hold ¥14.6 trillion in assets.
Stocks
An interim Phase 3 analysis found a 58% lower risk of metastasis or death when darolutamide was added to standard treatment.
Stocks
The grocery delivery company is exploring a possible sale, though discussions remain preliminary and no deal is assured.
Stocks
ASELSAN expects the contract to support revenue, while Borusan Boru begins assessing a wholly owned subsidiary for Turkish operations.
Stocks
Wells Fargo, Arm Holdings and Intuit are among six new companies objecting to tokenized listings on the joint platform.
Stocks2 sources
The two-thousand-dollar iPhone Duo drew launch-day buyers in Beijing and Singapore, while some new orders showed delivery estimates reaching January.
Stocks3 sources
The rating outlook is negative as JCR cites liquidity pressures and reviews a proposed delay to a bond coupon payment.
Stocks
The court said transport rules need updating and that a commercial activity cannot be broadly prohibited by judicial ruling.
Stocks
Interim phase III results showed a significant reduction at 37 weeks, while the study continues to track kidney function.
Stocks2 sources
The proposed British Columbia expansion targets commercial production in 2033, with a construction decision expected early next year.
Stocks
The insurer plans to reduce staff by 2030, consolidate regional offices and negotiate the changes with its works council.
Stocks3 sources
Zymeworks will receive $55 million upfront and may earn milestone payments and royalties as Roche takes global development rights to ZW209.
Stocks2 sources
Volkswagen and IG Metall are reviewing a 2024 agreement as the company pursues new savings and the union presses for higher pay.
Stocks2 sources
The reported offer would value Evonik at more than €11 billion, while the company and BASF declined to comment.
Stocks
Six-year NATALEE results showed a 19.1% lower risk of death with Kisqali plus endocrine therapy, while Novartis shares edged lower.
Stocks2 sources
The company cited efficiency goals as it announced a restructuring charge and raised its full-year earnings forecast after third-quarter results.
Stocks3 sources
The new facility has annual capacity of nearly four million machines, and Arçelik says it exports 44% of production to 106 countries.
Stocks2 sources
The companies had agreed on key financial terms, but could not settle who would lead the proposed combined business.
Stocks
The reported talks with tower companies could help SpaceX build a nationwide carrier, while shares moved in opposite directions after the news.
Stocks3 sources
The planned Queensland project is set to begin production in 2029 and support higher annual capacity at Weipa.
Stocks
The chipmaker cited market swings and share-price trends as it reassesses funding options for its subsidiary’s expansion.
Stocks5 sources
The company has asked bondholders to move an October interest payment to April, with a vote scheduled for November 23.
Stocks
The regulator also ordered license cancellations for 28 people; reports gave different counts for complaints tied to Anel Elektrik.
Stocks3 sources
The phase 3 results showed lower recurrence and spread risks with the personalized vaccine and Keytruda, but Moderna shares fell sharply.
Stocks2 sources